U.S. market projected to surpass USD 1.00 billion by 2035, while Europe advances through high PCI volumes and stricter MDR-driven vascular device standards.Austin, United States, May 22, 2026 (GLOBE ...
In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. LeMaitre Vascular, Inc. stands fifth among them. LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a medical device ...
Haemonetics is shaking up the large-bore closure space market with the acquisition of Vivasure Medical, the developer of the PerQseal Elite. The acquisition includes an upfront cash payment of $116 ...
The peripheral vascular device market will rise from $10.4B in 2025 to $14.8B by 2032, driven by drug‑coated balloons, IVUS, and minimally invasive PAD care. As device technologies advance, the ...
CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...
TCT 877: The PROVE registry: A prospective multi-center multi-national post-market registry of a short-frame supra-annular transcatheter aortic valve Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results